TRANSCRIPT 🔗
WEBVTT
00:00:00.000 --> 00:00:05.200
Welcome to Value-Based Voices, a podcast from the Association for Value-Based Cancer Care.
00:00:05.440 --> 00:00:15.279
Each episode dives into the shifting terrain of cancer care in the United States, exploring what value means in today's clinical, policy, and patient-centered environments.
00:00:15.679 --> 00:00:26.079
Our mission is to spark informed dialogue, promote transparency, and equip every stakeholder with the insight they need to navigate cancer care with clarity, confidence, and purpose.
00:00:31.120 --> 00:00:35.920
My name is Jason Sonic, and I'm joined today by Ted Slavski from the 340B Report.
00:00:36.079 --> 00:00:42.240
During today's episode, we're going to get an update on three prominent issues impacting the 340B program.
00:00:42.799 --> 00:00:55.600
First, CMS's recent decision to reduce the reimbursement rate from ASP plus 6 to ASP minus 28 to cover entities and certain other hospitals for drugs purchased at the 340B.
00:00:55.759 --> 00:00:56.880
This is very timely.
00:00:56.960 --> 00:00:59.119
We just heard this decision from CMS.
00:00:59.359 --> 00:01:01.439
We really appreciate Ted joining us.
00:01:01.679 --> 00:01:06.480
Number two, Ted's going to give us an update on the litigation on the 340B rebate model.
00:01:06.719 --> 00:01:13.439
And finally, we're going to discuss the latest doings on contract pharmacy, all of which are going to wind up in litigation.
00:01:13.519 --> 00:01:19.599
And stay tuned for Ted's predictions on how all the litigation is going to shake out.
00:01:19.760 --> 00:01:24.560
It is an honor to welcome uh Ted Slavsky to this call.
00:01:24.799 --> 00:01:33.359
I'm going to let him introduce himself in a few minutes, but uh, as you will hear, he's the editor-in-chief of something called the 340B Report.
00:01:33.599 --> 00:01:36.480
And I've been reading the 340B report for years.
00:01:36.640 --> 00:01:40.879
I mean, you you wouldn't look at it from Ted uh uh about how long it's been.
00:01:41.040 --> 00:01:42.319
He looks great, by the way.
00:01:42.480 --> 00:01:52.079
Um, it is the only place to get information on 340B, no matter where you sit on the spectrum about the 340B issues that we're going to discuss with 340B Red Large.
00:01:52.640 --> 00:02:03.680
I can't strongly recommend enough um reading and accessing the 340B reports, the podcasts, the slide decks, everything that Ted puts out is really great information.
00:02:03.920 --> 00:02:15.840
And we really appreciate you coming today and sharing some of your insight on three major policy issues that have that have occurred or ongoing really over the last, let's call it, eight to ten months.
00:02:16.000 --> 00:02:21.120
Um, number one, uh, just so everybody knows that Ted and I are going to talk about happened last Wednesday.
00:02:21.199 --> 00:02:30.800
It's hot off the press, and why we really appreciate your time, Ted, uh, which relates to the reduction of the hospital reimbursement
Load full transcript
rate for drugs purchased at 340B.
00:02:30.879 --> 00:02:37.120
Number two is to continue to talk about the rebate model, uh, which will uh give some further detail in a few minutes.
00:02:37.199 --> 00:02:40.479
And then number three, what's going on in in contract pharmacy.
00:02:40.639 --> 00:02:45.520
So we have a lot to cover on this uh issue, and we really appreciate your time, Ted.
00:02:45.680 --> 00:02:49.919
So you weren't always involved with the 340B report, right?
00:02:50.000 --> 00:02:54.080
There was a life prior to 340B, a very impressive one, I might add.
00:02:54.319 --> 00:03:00.560
So, Ted, why don't you start with a few words about yourself and how you came to the 340B report?
00:03:00.960 --> 00:03:02.319
Sure, that's right, Jason.
00:03:02.400 --> 00:03:05.360
Um actually began my career as a journalist.
00:03:05.599 --> 00:03:08.639
Um I uh actually started very early.
00:03:08.800 --> 00:03:22.400
I was the uh managing editor of my high school newspaper and then was the sports editor of my college newspaper at Tufts University, and then um decided to pursue a career in journalism and worked at U.S.
00:03:22.479 --> 00:03:25.680
News and World Report for close to four years.
00:03:25.840 --> 00:03:28.639
I had a great mentor there, David Gergen.
00:03:28.960 --> 00:03:33.120
Uh, David, as you may know, Jason, was an advisor to four U.S.
00:03:33.280 --> 00:03:41.199
presidents, both Democrats and Republicans, um, and was a wonderful um uh mentor to me over the years.
00:03:41.439 --> 00:03:46.159
And I talked to him about maybe moving to a career of public service.
00:03:46.319 --> 00:03:54.080
And uh he happened to be from Durham, North Carolina, and his father was a professor at a university called Duke University.
00:03:54.319 --> 00:04:06.960
So I ended up there at Duke for two years, and during my time at Duke, um, it was in the sort of the whole battle over trying to get the Clinton Healthcare Reform Initiative enacted.
00:04:07.120 --> 00:04:19.920
And I had the pleasure of working for uh Senate Majority Leader George Mitchell and Tom Dashell, who was the uh deputy um leader of the Senate Democrats at the time.
00:04:20.160 --> 00:04:31.600
And we tried um and failed to enact the uh healthcare, um the big Clinton Healthcare Reform Initiative, with Hillary Clinton playing a big role in that initiative.
00:04:31.680 --> 00:04:41.439
Um, but it was a great experience um and uh got to meet a lot of folks on both sides of the aisle and decided I would be an advocate.
00:04:41.519 --> 00:04:47.120
Um, started working for what uh was now called 340B Health.
00:04:47.199 --> 00:04:48.720
It used to have another name.
00:04:48.879 --> 00:04:52.160
It's the trade group for the hospitals in the 340B program.
00:04:52.560 --> 00:05:02.560
And I was there for 22 years um working on all the different advocacy issues, getting to know lawmakers and policymakers.
00:05:02.720 --> 00:05:06.319
And um, I was the CEO there for over 10
years.
00:05:06.560 --> 00:05:17.920
And then in 2018, I pivoted um and uh decided after a little while of contemplation to begin a news service on the 340B program.
00:05:18.079 --> 00:05:21.199
And it's grown tremendously, our newsletter.
00:05:21.279 --> 00:05:40.879
Um, we have lots of subscribers from all different stakeholders in the 340B world, from both the provider side, drug industry, lawyers, um, uh good lobbyists like you, um, who depend on the 340B report for all things 340B.
00:05:41.120 --> 00:05:47.439
And we're really proud of the work that we're doing covering this very complicated but important program.
00:05:47.920 --> 00:05:49.680
Yeah, I mean, uh agreed.
00:05:49.839 --> 00:05:51.279
Thank you for that wonderful introduction.
00:05:51.360 --> 00:05:56.560
You got uh really had the opportunity to work with some real lens lions of the Senate, right?
00:05:56.639 --> 00:05:57.519
Some real adults.
00:05:57.600 --> 00:06:04.000
And again, no matter where you sit, we we we miss some of those kinds of adult supervision uh these days.
00:06:04.079 --> 00:06:08.480
Uh and going forward, it'd be it'd be great to find some some more of those.
00:06:08.720 --> 00:06:18.720
And um you bring a lot of history here, a lot of important history, not only from a health policy point of view, but from a journalistic point of view and and well trained.
00:06:18.800 --> 00:06:23.680
And so that's why, you know, I I appreciate the uh and go to the 340B report.
00:06:23.759 --> 00:06:25.920
I want to sort of dive in.
00:06:26.079 --> 00:06:31.759
One of the major issues you've been covering is what is happening at the reimbursement rate at the hospital.
00:06:31.920 --> 00:06:46.560
Uh, by way of background, for our listeners who may not be aware, um, this is not the first time, but this is the second time now that CMS has finalized a reduction to the reimbursement rate for drugs purchased at the at a covered entity.
00:06:46.800 --> 00:06:54.959
Uh more specifically, CMS finalized an ASP minus 28% rate for most hospitals, for most drugs.
00:06:55.120 --> 00:07:16.399
There are exceptions in terms of, as I hinted, types of hospitals, exempt hospitals, children's hospitals, and no pain act drugs and pass-through drugs, but the overwhelming majority of both hospitals dish and non-pass-through separately paid drugs are now subject to an ASP minus 28 reduction starting January 1.
00:07:16.480 --> 00:07:18.319
And this policy just came out last week.
00:07:18.480 --> 00:07:20.480
You guys are getting this hot off the press.
00:07:20.720 --> 00:07:30.160
The first time this happened was during the first Trump administration, and the hospitals litigated and created a huge mess with a clawback, whatever, we might get into that in a minute.
00:07:30.480 --> 00:07:33.120
But Ted, you've got your finger on the pulse.
00:07:33.199 --> 00:07:42.079
What are the, I mean, most of us who are not as close to the hospital, certainly with their common letter and the
way CMS responded, anticipate the hospitals to litigate.
00:07:42.240 --> 00:07:47.360
What are your spidey senses telling you related to the litigation and when we might expect it?
00:07:47.759 --> 00:07:48.160
Sure.
00:07:48.240 --> 00:07:50.959
Um that that's a good history lesson, Jason.
00:07:51.040 --> 00:07:54.160
Um, it seems like it's deja vu all over again.
00:07:54.399 --> 00:08:08.480
Um it is uh uh as uh Jason referenced, there was actually a big Supreme Court decision um back, I think it was in maybe 2020 or so, 2018, uh 2022.
00:08:08.639 --> 00:08:09.040
Thank you.
00:08:09.199 --> 00:08:14.240
Thank you, Jason, for uh your great memory that overturned the cuts.
00:08:14.319 --> 00:08:24.480
Um and uh there have been uh efforts to reimburse the uh hospitals that were received these cuts um over the last few years.
00:08:24.639 --> 00:08:33.200
Um and um now we have this new proposal, which um is a very big cut um to the 340B hospitals.
00:08:33.360 --> 00:08:36.639
I do expect there to be another lawsuit.
00:08:36.960 --> 00:08:50.720
Probably uh the same folks who are suing now, uh sued last time will sue again, which would be a variety of hospital associations that are based here in Washington, where you and I are based, Jason.
00:08:50.960 --> 00:08:56.399
Um, and um whether they will be as successful uh this time around.
00:08:56.559 --> 00:08:59.120
They had a slam duck victory last time.
00:08:59.279 --> 00:09:02.159
It took a while, but uh the certainly the the U.S.
00:09:02.320 --> 00:09:04.480
Supreme Court fa ruled in their favor.
00:09:04.960 --> 00:09:06.480
That is uh an open question.
00:09:06.559 --> 00:09:10.559
And feel free to ask me more about the nuances of that if you'd like.
00:09:10.960 --> 00:09:12.559
Right, so Tell let's dive into that.
00:09:12.639 --> 00:09:13.919
I appreciate that opening.
00:09:14.159 --> 00:09:19.039
Um So you mentioned, right, the first time around, slam dunk.
00:09:19.120 --> 00:09:21.919
I mean, I make the jokes about the, I mean, it was slam dunk, right?
00:09:22.000 --> 00:09:23.120
You guys didn't do the survey.
00:09:23.360 --> 00:09:27.120
Survey says, right, in honor of may you rest in peace, Richard Dostamer.
00:09:27.200 --> 00:09:29.600
We're of the same age, we know who that is, right?
00:09:29.679 --> 00:09:30.879
These guys didn't do the survey.
00:09:30.960 --> 00:09:35.360
They show up in the beginning of this administration, they say they're gonna do a survey, they do the survey.
00:09:35.519 --> 00:09:38.480
Now they've done the survey, and we'll get into that in a minute.
00:09:38.720 --> 00:09:40.960
So, yes, the hospitals are gonna sue.
00:09:41.120 --> 00:09:46.240
Do you have a sense on sort of like how much is their legal case stronger now?
00:09:46.559 --> 00:09:48.639
And are they gonna see conjunctive relief?
00:09:48.720 --> 00:09:51.039
And do you think this goes into effect January 1?
00:09:51.279 --> 00:09:53.120
So let's take those in turn.
00:09:53.360 --> 00:09:56.720
Um, what do you uh what are their causes of action gonna be?
00:09:56.799 --> 00:09:56.960
Sure.
00:09:57.840 --> 00:10:04.000
Now keep in mind, um, unlike you, Jason, who you have a law degree, I just pretend to have a law degree.
00:10:04.159 --> 00:10:07.360
So there's a very thin-line difference here, Ted, trust me.
00:10:07.679 --> 00:10:09.440
I could say my brother's a lawyer.
00:10:09.600 --> 00:10:22.639
Um, but um I do they they are um they're very likely uh to sue, and they're gonna uh likely try to block it altogether through some sort of injunctive relief.
00:10:23.039 --> 00:10:34.399
Um and they may not have as strong a case this time, um, because um it is true that CMS did conduct a survey this time.
00:10:34.799 --> 00:10:51.519
Now, as as think as you're aware, my understanding is that they ended up using data from HERSA, the ceiling price data, rather than the survey results um to determine the reduction in reimbursement.
00:10:51.840 --> 00:11:02.879
So I'm not entirely sure if um they will actually have a case here, and they might um because they didn't end up using the survey results.
00:11:03.039 --> 00:11:24.000
So I don't know for sure whether they will be successful, but I can guarantee you they're gonna try um just because it's a uh a significant cut in reimbursement, um, one that um the hospitals believe is unfair and that will result in um undermining patient care.
00:11:24.080 --> 00:11:27.039
Um and we're I'm happy to talk more about that.
00:11:27.279 --> 00:11:37.279
Um, but there there is certainly going to be another effort um to try to block uh this just this recent action that occurred just last week.
00:11:37.759 --> 00:11:42.159
Yeah, it's very when you read the preamble, there is some really pointed language.
00:11:42.320 --> 00:11:51.519
I don't know, Ted, if you had a chance to digest what what the you know the common response that is in every final rule related to this policy in particular.
00:11:51.600 --> 00:11:55.200
Uh and they get the agency tries to say some of that, right?
00:11:55.279 --> 00:11:55.840
And I agree.
00:11:55.919 --> 00:12:10.559
At first I thought they have to, but they are bound by the survey and it said for that drug for that year, and SEMAS sort of responds, look, well, we read the statute this way to say that the reimbursement rate is for that drug.
00:12:10.720 --> 00:12:20.159
ASP methodology 28, we comply there, and then survey taking into account the language in the statute allows them to bring in Hearse's data.
00:12:20.240 --> 00:12:23.919
And we took into account 33 and we we landed at 28.
00:12:24.159 --> 00:12:24.879
So I agree.
00:12:25.200 --> 00:12:29.279
It's gonna be, it's not as much of a slam dunk had they not done the survey.
00:12:30.320 --> 00:12:41.519
And then the other part that the agencies talk about is this sort of promotion, this program about the hospitals not responding and then the survey rate.
00:12:41.600 -->
00:12:50.080
And then CMS sort of says, well, you guys, the hospitals you're promoting not responding, and now you can't complain about a low response rate.
00:12:50.399 --> 00:13:04.159
What do you what would what was your reaction when you saw that, that kind of back and forth that CMS talks, at least describes in the preamble related to the comments that they received on the on their 33.4 negative response uh proposal?
00:13:04.480 --> 00:13:16.080
Yeah, I mean, I think what the trade associations are arguing, and I'm uh a former CEO of one of those trade groups, uh, so that is uh full disclosure as we discussed.
00:13:16.240 --> 00:13:23.200
Um, I think that they're arguing that um that survey was not uh required.
00:13:23.360 --> 00:13:25.919
You're not required to respond to the survey.
00:13:26.080 --> 00:13:38.159
There is some dispute over whether there is an actual requirement to actually have submitted data to the contractors that were working with CMS on collecting the data.
00:13:38.320 --> 00:13:50.639
Um and you are correct that the uh there was not a large uh response rate from those hospitals in the 340B program, much uh larger from the non-340B hospitals.
00:13:50.799 --> 00:13:59.600
Um and uh whether that is um gonna be a big factor in the decision will be uh will be interesting to see.
00:14:00.000 --> 00:14:00.159
All right.
00:14:00.639 --> 00:14:17.200
We'll leave it up to somebody who's a lot smarter than we are at the judicial uh branch to sort of uh parse that piece out, as well as some other, I'm sure, um, important like statutory interpretations about relevant characteristics and everything else we talked about.
00:14:17.440 --> 00:14:32.159
But for our listeners who really, I mean, this is real weedsy but nerdy and nerdy, but it is kind of interesting to see how CMS and the hospitals are going at each other on this issue of, like you said, it wasn't required and the survey and all of that.
00:14:32.320 --> 00:14:38.960
So it's it's gonna be very interesting to see how the how a judge and a court um respond to that.
00:14:39.120 --> 00:14:41.600
I personally think I agree that they're they're gonna sue.
00:14:41.679 --> 00:14:44.080
I don't know that they're gonna get injunctive relief.
00:14:44.480 --> 00:14:45.440
Um, right?
00:14:45.600 --> 00:14:54.559
Uh your point about patient harm will, if they're going to get across the finish line for injunctive relief, will will hopefully will get them there.
00:14:54.639 --> 00:15:00.080
And also, hey, Your Honor, look at the mess we have with the clawback from 18 to 22.
00:15:00.159 --> 00:15:05.440
It's just better to pause this for now so we don't have to do this all over again years from now, right?
00:15:05.519 --> 00:15:09.519
I mean, this clawback issue has been an issue from the first time.
00:15:10.240 --> 00:15:16.399
Um what are your thoughts about how the hospitals that back and forth, the advocacy went from 0.5 to 3 down to 2.
00:15:17.039 --> 00:15:18.960
How
are the hospitals thinking about that right now?
00:15:19.360 --> 00:16:09.200
Yeah, I mean, I think that the reason, just so to explain to our audience why there's a clawback, um the uh this rule or this uh regulation has to be budget neutral, um, which is uh an interesting point because um the hospitals uh are argue, the 340B hospitals argue that this is actually not going to be beneficial um to patients or um or to anyone because uh whatever uh reduction in reimbursement is going to happen on um on drug reimbursement, uh the other hospitals that are not 340B are are gonna get an increase, as well as the 340B hospitals are gonna get an increase on their non-drug payments for Part B programs.
00:16:09.440 --> 00:16:11.279
So it's it's kind of complicated.
00:16:11.360 --> 00:16:15.519
The whole clawback thing, it's very difficult to understand.
00:16:15.600 --> 00:16:25.039
But I think basically CMS felt like had to claw back the money in order to keep this as a budget neutral uh move.
00:16:25.279 --> 00:16:32.320
Um and uh that is one that is a nuance uh related to this that a lot of people don't understand.
00:16:32.480 --> 00:16:41.919
So it it's a cut, but then there's actually a reallocation to the entire uh any hospital that gets um payment through the PPS system.
00:16:42.000 --> 00:16:47.519
So it's which created a little bit of a divide within the hospitals writ large, right?
00:16:47.679 --> 00:16:51.200
Um, because the for-profit hospitals were like, good, give me my five percent, right?
00:16:51.279 --> 00:16:57.440
Because the minus 28 created a 7% reallocation the way you described it, but now you're clawing back to.
00:16:57.840 --> 00:17:02.879
So it this is a great, again, for those nerd for our nerds like you, right?
00:17:02.960 --> 00:17:05.519
It's a great it's a great, it's very interesting policy.
00:17:05.759 --> 00:17:09.519
Um and it doesn't just impact the hospitals, right?
00:17:09.599 --> 00:17:14.240
We have the physician community that also treats obviously patients.
00:17:14.720 --> 00:17:18.640
Uh and they've always wanted the discount to follow the person.
00:17:18.799 --> 00:17:25.920
They think that they support this policy because maybe back in the community, uh, why should they get more money than us, right?
00:17:26.000 --> 00:17:27.599
That's the position of the physicians.
00:17:27.759 --> 00:17:32.400
How do the hospitals view that dynamic with the physicians?
00:17:32.559 --> 00:17:40.160
How do they, you know, say, look, yeah, it's okay that we get a 28, 30, 40% spread here, but you docs can.
00:17:40.720 --> 00:17:44.400
Explain, what is your perspective on that, that positioning of the hospitals?
00:17:44.480 --> 00:17:52.640
How they, how they um, I don't want to use the word justify, but sort of say, look, yeah, we we in the hospital, we do do this, not the docs.
00:17:52.960 --> 00:17:53.359
Sure.
00:17:53.599 --> 00:17:55.200
No, that's a great question.
00:17:55.440 --> 00:18:07.200
Um, the what the uh hospitals argue um is that they serve a much larger volume of patients that are either low income or disabled.
00:18:07.440 --> 00:18:26.319
Um, there is um a MedPAC uh study um that found that 54% of the patients, cancer patients served at 340B hospitals, are uh either low income or disabled compared to 34% for the private physician offices.
00:18:26.400 --> 00:18:31.279
So that's a you know a big difference in the types of patients that are being treated.
00:18:31.519 --> 00:18:38.000
Also, the hospitals point out that they serve 77% of all Medicaid patients.
00:18:38.160 --> 00:19:00.640
So it's a um, these are important factors, and the uh the concern uh among the hospital community, particularly the safety net hospital community, is we can't take these cuts at the same time that we're about to go um with uh the big Medicaid cuts that are part of the big beautiful bill.
00:19:00.880 --> 00:19:10.240
Also, we have the uh the end of the um ACA subsidies for a lot of um Americans who are gonna who are losing their health insurance.
00:19:10.400 --> 00:19:14.880
Um and it's just uh I would describe it as a potential triple whammy.
00:19:15.200 --> 00:19:18.480
Um so it's that is the uh concern.
00:19:18.799 --> 00:19:29.359
Um and the providers in the 340B program would argue that the 340B program was never intended to be a subsidy program for the Medicare program.
00:19:29.599 --> 00:19:50.480
Um it's intended to uh, you know, there are you do pass on your discounts to the Medicaid program by billing an acquisition cost, but for uh Medicare, um it is not uh it was never intended to be uh something to help the either the Medicare pro program or private insurance.
00:19:50.880 --> 00:19:55.359
Now, so speaking of which, Ted, right, the other major stakeholder here is the patient, right?
00:19:55.519 --> 00:19:57.279
Is the Medicare beneficiary.
00:19:57.680 --> 00:20:05.279
And um they stand to benefit significantly with this P ASP minus 20.
00:20:05.359 --> 00:20:11.279
So for our listeners, right, that means their coinsurance obligation of 20% is 20% of a much lower number.
00:20:11.839 --> 00:20:16.240
And so how do the hospitals I get those numbers, okay, doc, right?
00:20:16.319 --> 00:20:19.200
This is we're very different, but the patient's the patient.
00:20:19.680 --> 00:20:27.039
And so how do you say to the patient, we need to collect more 20%, you know, of a higher number to cross-subsidize everybody?
00:20:27.200 --> 00:20:30.880
As does that does that work for the patients, for the beneficiaries?
00:20:31.200 --> 00:21:08.160
Yeah, I mean, it it it's a an argument that CMS makes um in their press release and in their messaging, but actually what the hospitals say is that 90% of the patients, the Medicare beneficiaries that would be impacted by this already have supplemental insurance, whether that is through their own private supplemental insurance, through the Medicaid program, or through other types of programs that um
are there to help patients who um who are gonna absorb these costs.
00:21:08.319 --> 00:21:20.000
So it's really um and when I talk to the hospital community, they say that this is a red hearing um and that it really is not going to help uh patients.
00:21:20.240 --> 00:21:27.440
In fact, uh they're gonna end up seeing higher costs on their non-drug um health care expenses.
00:21:27.599 --> 00:21:31.759
So it's really not a win for patients, is what they would argue.
00:21:32.400 --> 00:21:36.480
And, you know, um this is gonna shock you coming out of me, right?
00:21:36.559 --> 00:21:49.119
And I I agree with you completely because I also say that that reduction from whatever it is, minus twenty-eight, at the price point of the drug, the twenty percent of a lower number, is still mostly gonna be unaffordable.
00:21:49.279 --> 00:21:56.480
If they can't afford Medigap, these patients these beneficiaries, they're not gonna be able to afford the out-of-pocket on a reduced for that drug expense anyway.
00:21:56.559 --> 00:21:58.559
So I I agree with you that it's sort of a red herring.
00:21:58.640 --> 00:22:05.599
And just for our listeners to Understand what Ted and I are talking about was discussed in CMS's final rule.
00:22:05.759 --> 00:22:11.759
And CMS said, well, the reduction will also maybe help Medigap plans reduce their premiums.
00:22:11.839 --> 00:22:13.519
I don't know if you saw that part of it, Ted.
00:22:14.000 --> 00:22:21.920
And I actually laughed out loud with the concept of thinking that an insurance that they're going to reduce their premiums to the on the Medigap side.
00:22:22.079 --> 00:22:23.039
I don't know if you saw that too.
00:22:23.680 --> 00:22:26.319
I did not see that essence of it.
00:22:26.480 --> 00:22:30.480
I must say, Jason, you're you're even more of a policy wonk than I am.
00:22:30.640 --> 00:22:32.960
I did not get through the entire rule.
00:22:33.039 --> 00:22:35.279
Uh so I'm impressed.
00:22:35.759 --> 00:22:41.039
I mean, if we could deserve a laugh these days, Ted, I I I you should go and look at that.
00:22:41.200 --> 00:22:49.759
Now, similarly on this back and forth, you know, and a really interesting question that I've been fielding, and I want to get your response to is well, okay, Jason, wait.
00:22:49.920 --> 00:22:54.000
You're telling me fee for service is going to reimburse at minus 28.
00:22:54.400 --> 00:22:57.279
What about Medicare Advantage and what about commercial?
00:22:57.519 --> 00:23:04.319
Uh we didn't see much of a bleed when it was minus 22 and a half going over to commercial and Medicare Advantage.
00:23:05.119 --> 00:23:06.799
What are your sources telling you, Ted?
00:23:06.880 --> 00:23:08.400
Is that likely to happen, not happen?
00:23:08.559 --> 00:23:11.119
And then I'm happy to share my thoughts on that too.
00:23:11.440 --> 00:23:11.759
Sure.
00:23:11.920 --> 00:23:23.759
Um, actually, Jason, I'd be interested in hearing your thoughts because you said that the last
time there wasn't that much of uh the private insurance, uh insurers following the lead.
00:23:23.920 --> 00:23:32.559
Um I don't recall um what happened the last time, and I'd be curious what your thoughts on what might happen this time.
00:23:33.119 --> 00:23:40.240
I think uh when we and and minus 22 and a half, we didn't see many much market disruption at all, one way or however you look at it.
00:23:40.400 --> 00:23:53.519
Um when I when they when I'm asked about moving it over to commercial, I find it very hard to believe that the entity will take a lower price.
00:23:53.839 --> 00:24:00.799
Right, for all the reasons you just said 10 minutes in the last 10, 15 minutes about the way the economics are working in the hospital.
00:24:01.039 --> 00:24:15.440
So in a hospital near us, right, you go up to Johns Hopkins, which is a major dish hospital, it's not like Aetna United Blue Cross Blue Shield is gonna will be able to say to you, oh, well, Medicare fee for service is 28, we're gonna pay you minus 12, right?
00:24:15.519 --> 00:24:18.240
I mean, and Hopkins will say, no, we're not a network, right?
00:24:18.480 --> 00:24:20.720
So I I don't know how that would work.
00:24:20.880 --> 00:24:23.839
I mean, what uh what do you do what are your thoughts about that?
00:24:23.920 --> 00:24:24.799
I mean yeah.
00:24:25.039 --> 00:24:28.400
I think I think it will depend on the hospital.
00:24:28.559 --> 00:25:04.960
Um, because you know, you mentioned a Johns Hopkins, which is a prestigious academic medical center, and one that has uh market power in Baltimore and is uh one that has uh the ability to maybe have a little bit stronger negotiating uh power than a mid-sized hospital in another part of the country that has a for-profit down the street, that uh has got a larger uh insured population, and it maybe is a bigger player in that market.
00:25:05.119 --> 00:25:15.039
So I think it's gonna be a case-by-case situation um when it comes to uh the potential for this having um downstream effects.
00:25:15.519 --> 00:25:31.039
But you haven't heard um the hospitals say, hey, Ted, look, we are concerned, or during the common period, a health plan reached out and said, you know, if this is finalized, we want to renegotiate our 27, or maybe now, right?
00:25:31.279 --> 00:25:32.720
Well, let's talk about 28.
00:25:32.880 --> 00:25:35.759
You haven't heard it go that far yet, have you?
00:25:36.240 --> 00:25:53.039
Well, what I do remember about the last time this occurred is that uh a number of the private insurance plans did um did do some uh lower reimbursement, and now the hospitals are trying to get that that uh money back.
00:25:53.119 --> 00:26:03.279
Um, there have been some suits against some of the insurers um that thank you for reminding me, um, saying, wait a second, this was deemed illegal by the U.S.
00:26:03.440 --> 00:26:04.480
Supreme Court.
00:26:04.720 --> 00:26:11.200
Therefore, uh you owe us money for following um CMS's uh reduction.
00:26:11.359 --> 00:26:15.839
So I i it it should be interesting to see what will happen.
00:26:15.920 --> 00:26:36.960
But I know there is certainly a tremendous amount of concern and and frankly fear among the hospitals in the program that they're not gonna be able to handle both the reductions and reimbursement at the same time they're serving more uninsured patients and um and dealing with these uh enormous Medicaid cuts.
00:26:37.440 --> 00:26:41.839
So it may be, just to sort of wrap up this part uh before we head to the rebate model, right?
00:26:41.920 --> 00:26:46.640
So what we've learned is hospitals are gonna litigate uh as soon as possible, right?
00:26:46.720 --> 00:26:49.519
I'm sure the brief is imminent any day now.
00:26:49.599 --> 00:26:52.000
Uh they're gonna seek injunctive relief.
00:26:52.720 --> 00:26:58.640
And um back and forth in the preamble is probably a good indicator of what some of the arguments may be.
00:26:58.799 --> 00:27:00.480
The agency did the survey.
00:27:00.559 --> 00:27:04.000
Uh, but what I think you just said there at the end will be most interesting.
00:27:04.160 --> 00:27:17.440
It might be that having if assuming people learn from their history, which is, as you know, right, we know it's dangerous to assume, right, for all the obvious reasons here, that um the commercial may wait to see if this is actually sticks, right?
00:27:17.519 --> 00:27:19.440
Because of what you just said with the lawsuits.
00:27:19.599 --> 00:27:31.759
So maybe the right answer for can this go to Medicare Advantage slash commercial more broadly is based upon history, we may not know that until the litigation is fully resolved.
00:27:32.160 --> 00:27:33.839
That that seems to make sense.
00:27:34.000 --> 00:27:51.839
I uh I I do think that there's always a chance that we will have uh this, as I mentioned, the deja vu all over again and instances where Medicare Advantage programs and potentially commercial insurers will end up um with uh reducing reimbursement when they can.
00:27:52.160 --> 00:27:57.039
So um I think it's too early to tell, but we should keep a close eye on it.
00:27:57.759 --> 00:27:58.319
Absolutely.
00:27:58.480 --> 00:28:01.839
I love how you keep referencing Yogi Berra, by the way, deja vu all over again.
00:28:02.160 --> 00:28:02.400
Of course.
00:28:02.480 --> 00:28:12.160
Well, as you and I know from our discussion prior to this call, I'm a big Red Sox fan and you're a big Yankees fan, but somehow we can still be friends.
00:28:12.400 --> 00:28:15.759
Yes, very so appreciate that, of course.
00:28:15.920 --> 00:28:21.359
Um, and so let's speak of litigation of the hospitals, let's talk about the rebate model.
00:28:21.680 --> 00:28:21.920
Sure.
00:28:22.160 --> 00:28:22.480
Right?
00:28:22.720 --> 00:28:26.559
Um and so brief history for our listeners.
00:28:26.799 --> 00:28:38.240
Um manufacturers that have a maximum fare price are required by law to provide the lower of the 340B price or the maximum fare price at the point of set.
00:28:38.880 --> 00:29:00.559
So here we are at the 340B entity, and so what the manufacturer wants to do is sort of not have it be an upfront discount, want to make it into a rebate, hence the name rebate model, and has gone back and forth with the oversight agencies, HERSA, with I'm sure some CMS technical expertise in the background, and proposed a rebate model.
00:29:00.640 --> 00:29:12.079
Um, it was thrown out by the courts, and then CMS went back, excuse me, HERSA went back through the rulemaking, implemented, started another rebate model, and here we are at the litigation.
00:29:12.160 --> 00:29:17.440
And even the judge has sort of said, hey, Hursa, hey guys, hospitals, right?
00:29:17.680 --> 00:29:19.680
They do have the authority to do this.
00:29:19.920 --> 00:29:21.440
Hospitals are suing.
00:29:21.839 --> 00:29:23.759
Do you expect, how is this going?
00:29:23.920 --> 00:29:25.839
I mean, do you expect the hospitals to win again?
00:29:25.920 --> 00:29:28.160
Are they just delaying the inevitable?
00:29:28.319 --> 00:29:30.480
What give us an update from your side?
00:29:30.799 --> 00:29:37.920
You're going much closer to hospitals on what's going on with the rebate model and what the hospitals really expect they can ultimately achieve here.
00:29:38.400 --> 00:29:38.720
Sure.
00:29:38.880 --> 00:30:09.920
Just to uh to kind of go big picture for a minute, um, as you're aware, Jason, for uh the 34 years that the 340B program has been in uh uh enacted, it's been a program where there is an upfront discount, um, where the providers buy the drug at a very at a low price through the 340B program and then get reimbursed at sometimes a higher price, sometimes at acquisition cost if it's a Medicaid patient.
00:30:10.319 --> 00:30:19.599
But um it's generally one that has worked uh one way and has worked, uh the providers would argue very effectively.
00:30:19.759 --> 00:30:32.480
Um and uh so this would be a change, and it would be one that uh the providers are very concerned about uh having to float the costs of these very expensive drugs.
00:30:32.640 --> 00:30:39.839
They would be buying them at wholesale acquisition cost, which as you're well aware, Jason, is a very high price.
00:30:40.000 --> 00:30:47.680
Um and um the concern is uh trying to uh eventually get the rebate on these drugs.
00:30:47.839 --> 00:30:59.519
And so um the drug, uh the um, I'm sorry, the hospital groups once again have sued, um, AHA taking the lead, uh, along with the Maine Hospital Association.
00:30:59.680 --> 00:31:08.559
That would be Maine up in uh northern New England, um, and uh a number of hospitals uh throughout the country are part of that suit.
00:31:08.720 --> 00:31:18.240
And they went back to the judge in Maine, who last year ruled in favor of the hospitals and stopped the rebate pilot.
00:31:18.480 --> 00:31:36.079
And this time they're arguing, okay, um, Hirsa, you might have done a better job of going
through the deliberate process of um, you know, making sure that you take in input, that you give enough time for this to be implemented.
00:31:36.160 --> 00:31:46.400
Um, however, they're arguing you forgot one thing, you ignored all the comments that the providers submitted uh concerning um the rebate pilot.
00:31:46.640 --> 00:32:07.759
Um they the providers argue that um the comments came in 18 to 1 um ratio against the uh the rebate pilot, and that um that uh CMS, I'm sorry, HERSA gets confused between the two agencies since they're working so closely right now.
00:32:07.920 --> 00:32:27.759
Um HERSA uh ignored the comments and did not take into any uh into um uh uh consideration the enormous uh costs financially and administrative for the providers in the program to um to change to a rebate program.
00:32:28.079 --> 00:32:30.400
Um these are 25 different drugs.
00:32:30.559 --> 00:32:33.680
It's um a lot of time, a lot of energy.
00:32:33.920 --> 00:32:51.039
And the providers that I talk to, including not just hospitals but community health centers, HIV clinics, say that if we're gonna be spending lots of time submitting data to the drug industry, it takes us away from our day-to-day job, which is treating patients.
00:32:51.279 --> 00:33:02.640
And so there must be a way to come up and uh come up with a solution that doesn't require so much data submission and so much time with paperwork.
00:33:02.720 --> 00:33:06.480
And I'm happy to discuss that with you at some point, Jason.
00:33:07.119 --> 00:33:14.000
But so the the hospitals believe that that is gonna win the day, right?
00:33:14.079 --> 00:33:27.920
But even though they have these the see Hearst has the authority to allow this to happen on the rebate side, there's another obligation on the other side of that ledger, Ted, right, about giving it to the patient right away at the point of sale, preventing some duplicate discounts.
00:33:28.079 --> 00:33:32.240
It is also an obligation on the other side on both sides, if you will.
00:33:32.799 --> 00:33:41.200
Um some of those other public needs, don't those override what we are trying, what they are trying to prevent here at the end.
00:33:41.359 --> 00:33:51.920
Once they get over the burden or once they get over the hump of implementing it, should be a smooth process and it will be at some point uh seamless.
00:33:52.160 --> 00:33:55.519
Couldn't it why be why prevent that from happening?
00:33:55.680 --> 00:34:03.119
It will be better in the long run because of the patient gets what they need right away, the manufacturer's obligated what it is right away.
00:34:03.279 --> 00:34:08.559
And then to some extent, the hospitals are able to do this and comply with what there's needed on that side.
00:34:08.719 --> 00:34:13.119
Plus, they're we're doing it on the 340B for CPI and other places.
00:34:13.519 --> 00:34:16.559
Why so much the resistance here on the rebate model?
00:34:16.719 --> 00:34:18.239
Give me some more detail on that.
00:34:18.639 --> 00:34:43.199
Yeah, um, you know, the the hospitals and um and other covered entities, the smaller covered entities like the health community health centers, um, you know, uh HIV clinics, et cetera, et cetera, say that they're already spending so much time submitting data to the drug industry for the different rules that they have related to the contract pharmacy program.
00:34:43.519 --> 00:34:45.599
And this is just overwhelming.
00:34:45.840 --> 00:34:59.360
And that it's they're also gonna not only have to hire um additional staff to help um comply with this, but they also have to get vendors, pay vendors to help run these programs.
00:34:59.599 --> 00:35:08.880
So um the uh HERSA somehow said that it would only take five hours a week to uh to implement the pilot program.
00:35:09.360 --> 00:35:14.960
And AHA and the other groups have argued that it's gonna take a lot more time than that.
00:35:15.119 --> 00:35:20.880
Um my sympathy um just from my previous experience is uh to the providers.
00:35:21.039 --> 00:35:33.679
Um uh but you know, I do do think that there should be ways to address issues such as a duplicate discount that could be potentially more of a win-win um situation.
00:35:34.159 --> 00:35:36.400
So let's double-click on that for a second, Ted.
00:35:36.559 --> 00:35:45.519
What would the ha what uh are the hospitals offering any alternative solutions to effectuate the MFP that's not the rebate model?
00:35:46.239 --> 00:35:51.440
Yeah, um they have argued for what would be described as a neutral clearinghouse.
00:35:51.519 --> 00:35:58.079
Um it would be uh basically overseen by the government um rather than a drug company.
00:35:58.239 --> 00:36:13.679
Um, and that information any type of information that would be submitted, claims submission, should go to a third party that is not um uh have any affiliation or uh to the drug industry.
00:36:13.840 --> 00:36:37.760
Um and that is their, they think would be the way to resolve this issue without having to go through all of the the changes that are going on right now and the the the enormous amount of time that the these providers are spending trying to uh comply with the various requests from the drug industry to submit uh data.
00:36:38.320 --> 00:36:41.440
Why do you think HERSA has not taken that recommendation?
00:36:41.920 --> 00:36:57.920
I think HERSA has said that they don't have the authority to go ahead and um move forward with a neutral clearinghouse, um, that it would require Congress to pass legislation that would allow that to go forward.
00:36:58.159 --> 00:37:08.239
Now, there is um in all of the bills that are currently pending in Congress related to 340B, pretty much all of them include this neutral clearinghouse.
00:37:08.480 --> 00:37:18.960
Whether any of those bills pass the uh finish line, certainly um before uh the uh lame duck Congress has done is a is an open question.
00:37:19.199 --> 00:37:39.760
But I do think eventually we're gonna
turn to a uh some sort of vendor that is not uh necessarily being paid for by the drug companies, and one that um I think both providers and manufacturers can feel is like an honest broker in this process.
00:37:40.239 --> 00:37:46.719
When what refresh my recollection on the timing here, um, we're it's already November 9th.
00:37:46.800 --> 00:37:48.079
It's hard to believe, right?
00:37:48.159 --> 00:37:52.559
This is we got more draw, right, 27 is around the corner.
00:37:52.880 --> 00:37:55.360
When will the judge in Maine respond?
00:37:55.519 --> 00:37:56.719
Is there a timeline here?
00:37:57.039 --> 00:37:58.880
Yeah, that's a good question, Jason.
00:37:58.960 --> 00:38:14.320
Um tomorrow's issue of 340B report will have a story that the oral arguments for uh the hospital's uh request for preliminary injunction will occur on November 18th in Portland, Maine.
00:38:14.480 --> 00:38:22.880
Um, we will have uh one of our reporters, Shannon Young, uh, flo uh uh going up to Portland to cover that those oral arguments.
00:38:23.039 --> 00:38:30.320
And it'll be a very interesting case because this time around, the drug companies are interveners in the case.
00:38:30.639 --> 00:38:38.639
Last time around, it was the hospitals versus HERSA, and the hospitals were uh persuasive.
00:38:38.880 --> 00:38:42.719
Um now the drug companies are going to be part of this uh debate.
00:38:42.800 --> 00:38:52.400
And the drug companies, as you know, hire hire some of the top lawyers in the nation, some of them who have uh argued many Supreme Court cases before.
00:38:52.559 --> 00:38:56.239
Um, so it'll be interesting to see how that comes along.
00:38:56.480 --> 00:39:02.719
Um, but that that we're starting to move forward with the November 18th um oral argument date.
00:39:03.360 --> 00:39:11.280
And they moved for, like you said, uh injunctive relief such that we expect some decision before the end of the year, right?
00:39:11.360 --> 00:39:12.079
To state the obvious.
00:39:12.400 --> 00:39:12.559
Yes.
00:39:12.800 --> 00:39:14.239
That that that's the goal.
00:39:14.400 --> 00:39:26.639
Um as you may recall, Jason, last year the decision was made on December 29th, and then it went to the appellate court that I think on January 2nd um made its decision.
00:39:26.880 --> 00:39:32.639
So um I think you and I may be not exactly having a great time over the holidays.
00:39:33.119 --> 00:39:33.519
Right.
00:39:33.679 --> 00:39:44.639
Um Yeah, so speaking of the courts and speaking of the Supreme Courts, let's let's finish up uh our conversation talking a little bit about contract pharmacies.
00:39:44.960 --> 00:39:54.960
Uh and this emanated from, yeah, again, Trump won, about requiring certain pricing at the contract pharmacy of manufacturers.
00:39:56.000 --> 00:40:06.480
Uh and so that went to the courts, and the courts said no, um, it can't happen at the feds, and then the state stepped in and the state started passing laws.
00:40:06.639 --> 00:40:12.880
If you want to do business in this state, you need to provide this price at this litigation ensued.
00:40:13.440 --> 00:40:14.960
And now we have a split, right?
00:40:15.039 --> 00:40:22.800
We have the fourth circuit saying dormant commerce clause prevents, and we have other circuits in the country saying, no, the states can do this.
00:40:23.360 --> 00:40:24.880
Two-part question, Ted.
00:40:24.960 --> 00:40:27.199
Number one, sort of, did I I characterize that?
00:40:27.360 --> 00:40:29.519
I I think pretty would correct me if I'm wrong.
00:40:29.679 --> 00:40:37.360
And then number two, I'm under the understanding, right, that we're gonna the farmers gonna keep litigating, litigating, try to get to the Supreme Court.
00:40:37.519 --> 00:40:39.760
Uh is that the perception on the other side?
00:40:39.920 --> 00:40:42.079
I mean, you cover that aside as well.
00:40:42.159 --> 00:40:48.880
Uh uh is everybody just sort of residing itself to the fact that we're gonna wind up at the Supreme Court here?
00:40:49.679 --> 00:40:50.880
That's a good question.
00:40:51.039 --> 00:41:14.159
So um there are 23 states that have passed laws that have basically say drug companies, you cannot impose restrictions on access to 340B discounts so that you um cannot say that you can only get access to 340B pricing at the in-house pharmacy or at one contract pharmacy.
00:41:14.320 --> 00:41:24.000
Um, you should be allowed to uh patients should be able to get it at any of the contract pharmacies that a provider contracts with.
00:41:24.320 --> 00:41:35.440
Um those have for the most part been upheld by uh by judges, um, with the exception of the uh Maryland and West Virginia laws.
00:41:35.599 --> 00:41:52.559
Um those were uh two to one uh uh ruled in favor of the drug industry and said that you're right, that uh that is these laws are preempted by federal law, and that federal law um is uh what determines uh what's going to happen here.
00:41:52.960 --> 00:41:58.320
Ted, is was the only difference the judge, or was there a substantive difference in the law that led to the outcome?
00:41:58.800 --> 00:42:13.760
Uh well, I mean, they had different uh arguments and there were a bunch of different uh once again, I'm not a lawyer, but there is stuff about takings and all these other things related to um what's permissible and what is not permissible.
00:42:14.000 --> 00:42:29.599
And um when does it basically the the main argument that the the that the states have made and the providers have made is that this is a law that is focused on the distribution of drugs, not on the price of drugs.
00:42:29.840 --> 00:42:36.559
And the drug companies are arguing no, it's actually um sort of an expansion of the 340B program.
00:42:37.119 --> 00:42:51.599
And um the providers have said, well, we used uh we had contracts with um with various retail partners for 20 some years, and you never had an issue with it, and you're suddenly suing us in 2020.
00:42:52.000 --> 00:42:54.880
So there is all of these backs and forths.
00:42:55.039 --> 00:43:01.920
There was a big um appellate court um hearing in Richmond, Virginia, which is the Fourth Circuit.
00:43:02.079 --> 00:43:20.400
A few weeks ago, the full 15 uh judge panel decided to take on the case, which indicates that there is um some question of whether that two to one decision in favor of the drug industry will actually um uh survive.
00:43:20.639 --> 00:43:22.960
Um, so that is the one case.
00:43:23.039 --> 00:43:33.760
If if the jud if the judges rule in favor of um the state, then we're not having a split court, uh split circuit decision.
00:43:33.920 --> 00:43:43.920
So we shall find out in the next, I would think the next few weeks uh where that that larger panel um subside uh you know decides to go.
00:43:44.079 --> 00:43:49.679
But the other um all of the other appellate court decisions have been in favor of the states.
00:43:50.559 --> 00:43:52.960
So, Ted, you've been very generous with your time.
00:43:53.119 --> 00:43:54.239
I'm gonna get you out of here.
00:43:54.320 --> 00:43:56.320
We're gonna do a little predictions here, right?
00:43:56.400 --> 00:43:59.440
We've spent time covering three issues, all heavy.
00:44:00.159 --> 00:44:05.599
Litigation involved, so we can actually do a um predictions.
00:44:05.760 --> 00:44:07.360
We can have a little back and forth here.
00:44:07.599 --> 00:44:09.280
So we covered three issues.
00:44:09.440 --> 00:44:12.800
All will litigate by the end of the next couple of Supreme Court terms.
00:44:12.880 --> 00:44:18.079
All all the justices might be better 340B experts than you and me, but the way the way we're going.
00:44:18.320 --> 00:44:19.760
All right, number one, Ted, right?
00:44:19.840 --> 00:44:22.239
The hospitals are going to sue on minus 28%.
00:44:23.760 --> 00:44:25.199
They're going to win or they're going to lose.
00:44:25.360 --> 00:44:26.079
Well, there's two, right?
00:44:26.159 --> 00:44:29.360
Are they going to win on uh injunctive relief?
00:44:30.239 --> 00:44:36.079
Um, I would say that they are going to maybe not win on injunctive relief.
00:44:36.159 --> 00:44:50.480
Um, and perhaps uh that uh it will continue to be battled through the courts um and maybe we'll make it to the Supreme Court just like the last uh Part B big cut um back uh back in the uh uh 2020.
00:44:50.880 --> 00:44:50.960
two.
00:44:51.119 --> 00:44:52.559
So we may have deja vu all over again.
00:44:54.159 --> 00:44:57.599
I think it was 2018 or 2017 when the cuts went into place.
00:44:57.760 --> 00:44:57.920
Yeah.
00:44:58.239 --> 00:45:00.559
Yeah, so that's deja vu all over again over there.
00:45:00.719 --> 00:45:01.760
All right, number two.
00:45:02.000 --> 00:45:03.840
We're on the rebate model.
00:45:04.239 --> 00:45:04.400
Yes.
00:45:04.639 --> 00:45:05.760
What is your prediction there?
00:45:05.920 --> 00:45:07.039
That's uh coming.
00:45:07.199 --> 00:45:12.159
Um and so does that go in or does that get reversed?
00:45:12.639 --> 00:45:24.719
Um I would say that it will, this is just a prediction that uh that the uh HURSA and the drug companies will potentially win that one.
00:45:24.880 --> 00:45:29.440
Um whether it gets overturned at the appellate level, we shall see.
00:45:29.599 --> 00:45:40.159
Um it is um uh an appellate level that I think is pretty sympathetic to the providers in the program, and we'll see if we'll end up at the Supreme Court on that one.
00:45:40.559 --> 00:45:43.679
And then last but not least, of course, the contract pharmacy.
00:45:43.760 --> 00:45:44.800
We do have the Richmond.
00:45:45.039 --> 00:45:51.199
I guess the Richmond is uh is uh is a real wild card, not real wild card here, but a real determining factor here.
00:45:51.280 --> 00:45:58.239
So maybe the prediction isn't on rich on Supreme Court, but what do you think about what's gonna happen on the Richmond Court?
00:45:58.639 --> 00:46:14.000
Well, I mean, I listened to the uh oral arguments, and there were some uh some judges that were very uh strongly backing the drug industry side, and there were a few judges that were very vocal on the other side.
00:46:14.159 --> 00:46:16.000
Um, so it's hard to tell.
00:46:16.079 --> 00:46:26.559
Um, it was certainly, you know, um, as I mentioned before, the drug companies have really, really top-flight lawyers um who know how to argue these cases.
00:46:26.639 --> 00:46:35.039
Um, and then you've got these two state lawyers who may not be as uh sophisticated or as um experienced.
00:46:35.280 --> 00:46:42.159
I thought the state lawyers did a fairly good job, um, but I I it I'd say 50-50 on that one.
00:46:42.239 --> 00:46:47.360
Um well I'd say a t uh a coin toss on who's gonna win in that in that case.
00:46:47.840 --> 00:46:51.599
Well, um so thank you, thank you for all of that, Ted.
00:46:51.679 --> 00:47:01.360
And I I'll I'll say to our listeners that the first place and the best place to find out whether or not Ted was correct is to, of course, go to the 340B report, right?
00:47:01.440 --> 00:47:05.119
Ted is to get a get a prescrip a subscription to to that.
00:47:05.199 --> 00:47:08.480
So tell us how we how our listeners can can subscribe.
00:47:08.800 --> 00:47:09.440
Sure, sure.
00:47:09.519 --> 00:47:19.760
Um they go to 340breport.com um and then just hit the subscribe button, and we're happy to offer a 25% discount.
00:47:19.840 --> 00:47:27.280
Um, and we'll provide more details of that to uh Jason and the team um after this conversation.
00:47:28.800 --> 00:47:30.159
Thank you very much, Ted.
00:47:30.239 --> 00:47:34.480
And even without the discount, I think there's a lot of value in in the 340B report.
00:47:34.559 --> 00:47:37.679
So we appreciate you offering that um to our listeners.
00:47:37.840 --> 00:47:41.679
And with that, thank you all for participating and for listening.
00:47:41.840 --> 00:47:46.159
And Ted, uh I look forward to seeing if your predictions come true.
00:47:46.400 --> 00:47:46.880
Thank you very much.
00:47:47.280 --> 00:47:47.679
Okay, great.
00:47:47.760 --> 00:47:48.000
Thanks.
00:47:48.079 --> 00:47:48.960
Take care, Jason.
00:47:49.199 --> 00:47:54.639
That wraps up this episode of Value-Based Voices brought to you by the Association for Value-Based Cancer Care.
00:47:54.800 --> 00:48:03.199
Thank you so much, Ted, for joining us on such short notice to share your insights and your predictions on the 340B program.
00:48:03.760 --> 00:48:07.360
And of course, to our listeners for joining the conversation.
00:48:07.599 --> 00:48:13.920
If you found today's discussion thought-provoking, be sure to subscribe to Value Based Voices wherever you get your podcasts.
00:48:14.320 --> 00:48:19.199
Also subscribe to the 340B report where you can see whether or not Ted's predictions come true.
00:48:19.519 --> 00:48:24.880
And please stay tuned for more episodes at Spotlight the Voices Shaping the Future of Cancer Care.